BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 36555443)

  • 41. A new light on Alkaptonuria: A Fourier-transform infrared microscopy (FTIRM) and low energy X-ray fluorescence (LEXRF) microscopy correlative study on a rare disease.
    Mitri E; Millucci L; Merolle L; Bernardini G; Vaccari L; Gianoncelli A; Santucci A
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1000-1008. PubMed ID: 28192171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Homogentisic acid induces aggregation and fibrillation of amyloidogenic proteins.
    Braconi D; Millucci L; Bernini A; Spiga O; Lupetti P; Marzocchi B; Niccolai N; Bernardini G; Santucci A
    Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):135-146. PubMed ID: 27865997
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transient pockets as mediators of gas molecules routes inside proteins: The case study of dioxygen pathway in homogentisate 1,2-dioxygenase and its implication in Alkaptonuria development.
    Bernini A; Galderisi S; Spiga O; Amarabom CO; Santucci A
    Comput Biol Chem; 2020 Oct; 88():107356. PubMed ID: 32823072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Alkaptonuria.
    Mistry JB; Bukhari M; Taylor AM
    Rare Dis; 2013; 1():e27475. PubMed ID: 25003018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Development of an Effective Therapy for Alkaptonuria - Lessons for Osteoarthritis.
    Gallagher JA; Dillon JP; Ranganath LR
    Rheumatol Immunol Res; 2021 Jun; 2(2):79-85. PubMed ID: 36465977
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Histological and Ultrastructural Characterization of Alkaptonuric Tissues.
    Millucci L; Bernardini G; Spreafico A; Orlandini M; Braconi D; Laschi M; Geminiani M; Lupetti P; Giorgetti G; Viti C; Frediani B; Marzocchi B; Santucci A
    Calcif Tissue Int; 2017 Jul; 101(1):50-64. PubMed ID: 28271171
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alkaptonuria is a novel human secondary amyloidogenic disease.
    Millucci L; Spreafico A; Tinti L; Braconi D; Ghezzi L; Paccagnini E; Bernardini G; Amato L; Laschi M; Selvi E; Galeazzi M; Mannoni A; Benucci M; Lupetti P; Chellini F; Orlandini M; Santucci A
    Biochim Biophys Acta; 2012 Nov; 1822(11):1682-91. PubMed ID: 22850426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced primary cilia length and altered Arl13b expression are associated with deregulated chondrocyte Hedgehog signaling in alkaptonuria.
    Thorpe SD; Gambassi S; Thompson CL; Chandrakumar C; Santucci A; Knight MM
    J Cell Physiol; 2017 Sep; 232(9):2407-2417. PubMed ID: 28158906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ashy ears.
    Rallis E; Kintzoglou S
    ScientificWorldJournal; 2010 Aug; 10():1530-1. PubMed ID: 20694448
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-term follow-up of alkaptonuria patients: single center experience.
    Bozaci AE; Yazici H; Canda E; Uçar SK; Guvenc MS; Berdeli A; Habif S; Coker M
    J Pediatr Endocrinol Metab; 2022 Jul; 35(7):913-923. PubMed ID: 35671204
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nitisinone Arrests but Does Not Reverse Ochronosis in Alkaptonuric Mice.
    Keenan CM; Preston AJ; Sutherland H; Wilson PJ; Psarelli EE; Cox TF; Ranganath LR; Jarvis JC; Gallagher JA
    JIMD Rep; 2015; 24():45-50. PubMed ID: 25940034
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Redox proteomics gives insights into the role of oxidative stress in alkaptonuria.
    Braconi D; Millucci L; Ghezzi L; Santucci A
    Expert Rev Proteomics; 2013 Dec; 10(6):521-35. PubMed ID: 24206226
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The molecular basis of alkaptonuria.
    Fernández-Cañón JM; Granadino B; Beltrán-Valero de Bernabé D; Renedo M; Fernández-Ruiz E; Peñalva MA; Rodríguez de Córdoba S
    Nat Genet; 1996 Sep; 14(1):19-24. PubMed ID: 8782815
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cytoskeleton Aberrations in Alkaptonuric Chondrocytes.
    Geminiani M; Gambassi S; Millucci L; Lupetti P; Collodel G; Mazzi L; Frediani B; Braconi D; Marzocchi B; Laschi M; Bernardini G; Santucci A
    J Cell Physiol; 2017 Jul; 232(7):1728-1738. PubMed ID: 27454006
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A quantitative assessment of alkaptonuria: testing the reliability of two disease severity scoring systems.
    Cox TF; Ranganath L
    J Inherit Metab Dis; 2011 Dec; 34(6):1153-62. PubMed ID: 21744089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early-onset ocular ochronosis in a girl with alkaptonuria (AKU) and a novel mutation in homogentisate 1,2-dioxygenase (HGD).
    Gucev ZS; Slaveska N; Laban N; Danilovski D; Tasic V; Pop-Jordanova N; Zatkova A
    Prilozi; 2011; 32(1):305-11. PubMed ID: 21822197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria.
    Laschi M; Tinti L; Braconi D; Millucci L; Ghezzi L; Amato L; Selvi E; Spreafico A; Bernardini G; Santucci A
    J Cell Physiol; 2012 Sep; 227(9):3254-7. PubMed ID: 22105303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ochronotic arthritis and ochronotic Achilles tendon rupture in alkaptonuria: A 6 years follow-up case report in China.
    Jiang L; Cao L; Fang J; Yu X; Dai X; Miao X
    Medicine (Baltimore); 2019 Aug; 98(34):e16837. PubMed ID: 31441856
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Calculi and intracellular ochronosis in the submandibular tissues from a patient with alkaptonuria.
    Taylor AM; Wilson PJ; Ingrams DR; Helliwell TR; Gallagher JA; Ranganath LR
    J Clin Pathol; 2010 Feb; 63(2):186-8. PubMed ID: 20154043
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.